Your browser doesn't support javascript.
Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study.
Cariou, Bertrand; Pichelin, Matthieu; Goronflot, Thomas; Gonfroy, Céline; Marre, Michel; Raffaitin-Cardin, Christelle; Thivolet, Charles; Wargny, Matthieu; Hadjadj, Samy; Gourdy, Pierre.
  • Cariou B; L'institut du thorax, UNIV Nantes, CHU Nantes, CNRS, Inserm, Département d'Endocrinologie, Diabétologie et Nutrition, CIC Inserm 1413, Hôpital Guillaume et René Laennec, Nantes, France. Electronic address: bertrand.cariou@univ-nantes.fr.
  • Pichelin M; L'institut du thorax, UNIV Nantes, CHU Nantes, CNRS, Inserm, Département d'Endocrinologie, Diabétologie et Nutrition, CIC Inserm 1413, Hôpital Guillaume et René Laennec, Nantes, France.
  • Goronflot T; CHU de Nantes, CIC Inserm 1413, Clinique des Données, Nantes, France.
  • Gonfroy C; Service d'Endocrinologie, Diabétologie, CH de Pontoise, Pontoise, France.
  • Marre M; Clinique Ambroise Paré Neuilly-sur-Seine, Centre de Recherches des Cordeliers, Université Paris Diderot, Paris, France.
  • Raffaitin-Cardin C; CH Robert Boulin, Libourne, France.
  • Thivolet C; Centre du Diabète DIAB-eCARE, Hospices Civils de Lyon et laboratoire CarMeN, INSERM, INRA, INSA, Université Claude Bernard Lyon 1, Lyon, France.
  • Wargny M; L'institut du thorax, UNIV Nantes, CHU Nantes, CNRS, Inserm, Département d'Endocrinologie, Diabétologie et Nutrition, CIC Inserm 1413, Hôpital Guillaume et René Laennec, Nantes, France; CHU de Nantes, CIC Inserm 1413, Clinique des Données, Nantes, France.
  • Hadjadj S; L'institut du thorax, UNIV Nantes, CHU Nantes, CNRS, Inserm, Département d'Endocrinologie, Diabétologie et Nutrition, CIC Inserm 1413, Hôpital Guillaume et René Laennec, Nantes, France.
  • Gourdy P; Département de Diabétologie, Maladies Métaboliques et Nutrition, CHU de Toulouse et UMR1048/I2MC, Université de Toulouse, Toulouse, France.
Diabetes Res Clin Pract ; 175: 108695, 2021 05.
Article in English | MEDLINE | ID: covidwho-1071243
ABSTRACT
In patients with diabetes hospitalized for COVID-19 in CORONADO study, 2.8% had a newly discovered. 2.8% had a newly discovered diabetes (NDD) mean age 60.2 ± 12.5 years and HbA1C 9.0 ± 2.5%. When compared with center, age and sex-matched patients with established type 2 diabetes, NDD was not significantly associated with a more severe COVID-19 prognosis.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Male / Middle aged Language: English Journal: Diabetes Res Clin Pract Journal subject: Endocrinology Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Male / Middle aged Language: English Journal: Diabetes Res Clin Pract Journal subject: Endocrinology Year: 2021 Document Type: Article